Veterinärmedizinische Universität Wien Forschungsinformationssystem VetDoc

Grafischer Link zur Startseite der Vetmeduni Vienna

Schneckenleithner Christine,

Beiträge für wissenschaftliche Veranstaltungen

Vortrag

Porpaczy, E; Tripolt, S; Holbl-Kovacic, A; Gisslinger, B; Bago-Horvath, Z; Casanova-Hevia, E; Clappier, E; Decker, T; Fajmann, S; Fux, DA; Greiner, G; Gultekin, S; Heller, G; Herkner, H; Hormann, G [and 22 others] (2018): JAK1/2 inhibitor therapy-associated lymphomas in myelofibrosis arising from a preexisting B-cell clone. Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Vienna, Austria, SEP 28 - OCT 2, 2018. Oncol Res Treat (41), S4 38-39.

Kollmann, K; Heller, G; Schneckenleithner, C; Warsch, W; Scheicher, R; Ott, RG; Schäfer, M; Fajmann, S; Schlederer, M; Schiefer, AI; Reichart, U; Mayerhofer, M; Hoeller, C; Zöchbauer-Müller, S; Kerjaschki, D [and 9 others] (2014): A new kinase-independent function of CDK6 links the cell cycle to Tumor surveillance. Joint Symposium between Taiwan-Austrian Research Communities.; MAY 4-11, 2014; Taiwan. 2014.

Kollmann, K; Heller, G; Schneckenleithner, C; Warsch, W; Scheicher, R; Ott, R; Schäfer, M; Fajmann, S; Schlederer, M; Schiefer, AI; Reichart, U; Mayerhofer, M; Hoeller, C; Zoechbauer-Mueller, S; Kerjaschki, D [and 9 others] (2013): A new kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis. -FASEB Science Research Conferences: Hematologic Malignancies; AUG 4-9, 2013; Vermont, USA.

Kernbauer, E; Jamieson, AM; Schneckenleithner, C; Sexl, V; Reichart, U; Strobl, B; Müller, M; Decker, T (2011): Conditional ablation of Stat1 reveals the antagonistic role of interferons in the clearance of the intracellular bacterial pathogen Listeria monocytogenes. 9th Joint Meeting of the International-Cytokine-Society/International-Society-for-Interferon-and-Cytokine-Research, Florence, ITALY, Italy, OCT 09-12, 2011. Cytokine (56), 1 10-11.

Poster

Tripolt, S; Porpaczy, EA; Hoelbl-Kovacic, A; Gisslinger, B; Bago-Horvath, Z; Casanova, E; Decker, T; Fux, D; Heller, G; Herkner, H; Kolbe, T; Kornauth, C; Mueller, M; Prchal-Murphy, M; Schiefer, AI [and 14 others] (2017): JAK2-Inhibitor Therapy Associated Lymphomas in Myelofibrosis: Distinct Clinico-Pathological Features Recapitulated in a Mouse Model. 59th Annual Meeting of the American Society of Hematology; DEC 09-12,2017; Atlanta, United States (USA). 2017.

Tripolt, S; Porpaczy, EA; Hoelbl-Kovacic, A; Gisslinger, B; Bago-Horvath, Z; Casanova, E; Decker, T; Fux, DA; Heller, G; Herkner, H; Kolbe, T; Kornauth, C; Mueller, M; Prchal-Murphy, M; Schiefer, IA [and 14 others] (2017): JAK1/2-inhibitor therapy associated lymphomas in myelofibrosis: Distinct clinico-pathological features recapitulated in a mouse model. 59th ASH Annual Meeting and Exposition; DEZ 9-12,2017; Atlanta, Georgia, United States (USA). 2017.

Tripolt, S; Schneckenleithner, C; Hoelbl-Kovacic, A; Heller, G; Sexl, V (2017): Lack of Stat1 Predisposes to a Diffuse Large B-Cell Lymphoma-Like Disease. 22nd Congress of the European-Hematology-Association, Madrid, SPAIN, Spain, JUN 22-25, 2017. Haematologica (102), S2 562-562. Open Access Logo

© Veterinärmedizinische Universität Wien Hilfe und DownloadsErklärung zur Barrierefreiheit